Jupiter Wellness Inc.

1.52
0.16 (11.76%)
At close: Sep 14, 2023, 8:00 PM

Company Description

Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products.

The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores.

It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand.

The company was formerly known as CBD Brands, Inc.

Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Jupiter Wellness Inc.
Jupiter Wellness Inc. logo
Country United States
IPO Date Oct 30, 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 10
CEO Brian Scott John

Contact Details

Address:
1061 East Indiantown Road
Jupiter, Florida
United States
Website https://www.jupiterwellness.com

Stock Details

Ticker Symbol JUPW
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001760903
CUSIP Number 48208F105
ISIN Number US48208F1057
Employer ID 83-2455880
SIC Code 2844

Key Executives

Name Position
Brian Scott John Chief Executive Officer & Executive Director
David Sandler CSCS, FISSN, FNSCA, HFD, HFS, M.S., MS, RSCC Chief Operating Officer
Douglas O. McKinnon Chief Financial Officer
Jarrett Boon Chief Operating Officer
Jason M. Roth Chief Operating Officer
Markita L. Russell Chief Financial Officer
Anthony Pedicelli Director of Marketing
Dr. Andy Goren M.D. Chief Medical Officer & Member of Scientific Advisory Board
Dr. Glynn Wilson Ph.D. Chief Scientific Officer & Chairman
Josh Wagner Chief Revenue Officer
Neil Luckianow Chief Commercial Officer
Richard A. Miller Sec.

Latest SEC Filings

Date Type Title
Apr 16, 2025 S-1/A [Amend] Filing
Apr 10, 2025 S-1/A [Amend] Filing
Apr 10, 2025 8-K Current Report
Apr 10, 2025 PREM14A Filing
Apr 04, 2025 8-K Current Report
Apr 04, 2025 S-1/A [Amend] Filing
Mar 31, 2025 8-K Current Report
Mar 28, 2025 10-K Annual Report
Mar 19, 2025 8-K Current Report
Mar 17, 2025 424B5 Filing